Search

OFEV 150 MG, Capsule molle

Details

--- Description
Pack Boite de 60
Strength (Dosage) 150 MG
Laboratory BOTTU S.A.
Ingredients Nintédanib
Therapeutic class Traitement de la fibrose pulmonaire idiopathique, inhibiteur de la tyrosine kinase
ATC code L01XE31
PPH $2,443.50
PPV $2,491.50
Refundable No
Refund base $0.00
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses Ofev est indiqué chez l'adulte pour le traitement de la fibrose pulmonaire idiopathique (FPI).
Ofev est également indiqué chez l’adulte pour le traitement d’autres pneumopathies interstitielles
diffuses (PID) fibrosantes chroniques avec un phénotype progressif.
Ofev est indiqué chez l'adulte pour le traitement de la pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS).
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.